Navigation Links
Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
Date:3/26/2013

2, Alexza and its Staccato system were presented the Frost & Sullivan 2012 Global Enabling Technology Award, based on Frost & Sullivan's analysis of the bipolar disorder therapeutics market.
  • In January 2013, J. Kevin Buchi was appointed to the Alexza Board of Directors.  Mr. Buchi has more than 30 years of pharmaceutical industry experience, most recently as Corporate Vice President, Global Branded Products at Teva Pharmaceutical Industries and previously served as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer, successively, during his tenure at Cephalon, Inc.
  • In February 2013, the European Commission granted marketing authorization for ADASUVE (Staccato loxapine), 4.5 mg and 9.1 mg inhalation powder, pre-dispensed, for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.
  • In March 2013, Peter W. Schineller joined the Company as Senior Vice President and Chief Commercial Officer.  Mr. Schineller brings more than twenty years of industry experience directing sales and marketing efforts at multinational pharmaceutical and specialty pharmaceutical companies for numerous diagnostic and therapeutic products.  In this newly created role, Mr. Schineller will be responsible for overseeing Alexza's global commercialization efforts and strategies for ADASUVE.
  • In March 2013, Alexza commenced the commercial manufacturing of ADASUVE in its facilities in Mountain View, CA.  Product manufactured at this facility will supply the U.S. and EU markets.
  • Financial Results - Periods Ended December 31, 2012 and 2011

    Alexza recorded $0.7 million and $4.1 million of revenues in the quarter and year ended December 31, 2012, respectively, compared to $1.9 million and $5.7 million in the same periods of 2011.  In 2012, Alexz
    '/>"/>

    SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
    2. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
    3. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
    4. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
    5. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
    6. Alexza Announces Management Promotions
    7. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
    8. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
    9. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
    10. Alexza Receives Complete Response Letter for Adasuve™ NDA
    11. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
    (Date:5/22/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ) ... Regulations on Pharmaceutical International Multi-Center Clinical Trials in ... This is first time in history, Chinese pharmaceutical ... clinical trials of drugs in China ... on March 1, 2015. The guidance provides an ...
    (Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
    Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
    (Date:5/24/2015)... May 24, 2015 Women's Excellence ... hair loss. Although it is unclear about the etiology ... environmental factors such as metabolism, nutritional deficiencies, thyroid abnormalities ... offer a comprehensive approach to evaluating the metabolic, nutritional ... they can help patients find a cause for their ...
    (Date:5/24/2015)... 2015 EnviroLeather™ by LDI, a ... – a classic, rugged leather grain with enhanced ... stains, including ink, to be easily removed. The ... for corporate, healthcare, hospitality and education environments. , ... goal of developing products that are more sustainable, ...
    (Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
    (Date:5/23/2015)... 23, 2015 On May 13, Nithyananda ... a youngster's yogic power learned through meditation and initiation ... in Bangalore, India. , Yogamaatha, a nine-year-old girl from ... high profile professionals attending the 2015 Business Advocacy Summit ... -- blindfolded. , In a demonstration that lasted ...
    (Date:5/23/2015)... May 23, 2015 On May 16, the ... The event was a 5k mud obstacle run that raised ... 2 million people worldwide, and the reason we participated was ... Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of ... Society.” , The event was not only attended by eXtreme ...
    Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
    ... The Foundation for a Drug-Free World received a Silver 2009 ADDY® ... ADDY Awards for each of six of its new public service announcements. ... ... consisting of a series of short films, each 30 to 60 seconds ...
    ... COPENHAGEN, March 20 , - On ... Republic, Hungary and Poland Claim Worsening Quality of Sleep,Thanks to the ... With 42% Making the Admission, Compared,to 17% of the UK(1) , ... Have Experienced Problems Sleeping,Over the Last 12 Months, but Only 19% ...
    ... Rivaroxaban could replace heparin after hip- or knee-replacement surgery ... The benefits of the experimental blood-thinning drug rivaroxaban outweigh ... panel said Thursday. , Rivaroxaban (Xarelto) could be one ... particularly for hip- and knee-replacement patients. , The panel ...
    ... Researchers at the University of Pennsylvania School of Medicine ... guides regeneration in an animal model. Results were published ... 300,000 Americans suffer peripheral nerve injuries every year, in ... sensory function, or both. These injuries are a common ...
    ... homes in Los Angeles County after being charged with a ... drugs seven years later, according to a new RAND Corporation ... to improve juvenile justice rehabilitation programs, according to the report ... . , Studies rarely track juvenile offenders for so long ...
    ... Inc. (Pink Sheets: ASFX) today confirmed that the Company ... s.r.l, manufacturer of the Thermofocus thermometer. The Company ... Thermofocus thermometers to select retailers in the United States. ... to continue to expand with a secure source of ...
    Cached Medicine News:Health News:Foundation for the Drug-Free World Honored with Seven ADDY Awards 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 3Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 4Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 5Health News:FDA Panel Backs New Anti-Clotting Drug 2Health News:Lab-grown nerves promote nerve regeneration after injury 2Health News:Lab-grown nerves promote nerve regeneration after injury 3Health News:Study finds most adolescents sent to group homes still involved with drugs/crime seven years later 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: